Spelling suggestions: "subject:"immunoassay"" "subject:"lmmunoassay""
91 |
Biosensing Using Long-Range Surface Plasmon-Polariton WaveguidesOleksiy, Krupin January 2016 (has links)
Specific detection of biological matter is one of the key elements in a wide range of modern fields such as food industry, medicine, environmental and pharmaceutical industries. Generally, current common methods of detection (e.g. ELISA) involve molecular labelling, requirements for well-trained personnel and lengthy experimental procedures such as bacteria culture. All of the above issues result in high costs for biological analysis, and consequently, high costs for medical service, therapeutic drugs and various food products. Biosensors, on the other hand, can provide quick and cheap solutions to these problems.
The field of optical biosensors is dominated by the method of surface plasmon resonance, which so far has attracted a lot of attention in the pharmaceutical industry. Investigation of long-range surface plasmon-polariton waveguides as an application for biosensing is still very novel, and most of it exists in the venue of theoretical discussions and modelling. The objective of this thesis is to demonstrate the capability of the novel optical biosensor based on plasmonic waveguides to selectively detect various biological entities in solutions.
The experiments were conducted on photolithographically fabricated sensors consisting of straight gold waveguides embedded in low-refractive index fluoropolymer CYTOP and a microfluidic channel. As a proof-of-concept, a demonstration of basic sensing experiments such as detection of change in refractive index of bulk solution and non-specific adsorption of bovine serum albumin is provided. Further investigation of the sensor capabilities involved specific detection of human red blood cells and leukemia markers. Red blood cell detection was based on ABO blood grouping and included the estimation of limit of detection and signal-to-noise ratio for single cell detection. Finally, a clinically relevant problem of B-cell leukemia marker detection was targeted. The sensor demonstrated the ability to detect the relative abundance of similar proteins (immunoglobulin kappa and lambda) in a complex fluid (human serum). In addition, an experimental study on the optimization of the sensor for sensitivity was conducted.
|
92 |
Studies of 51-Chromium immune assay for the detection of cell-mediated immunity to herpes simplex virusFeltt, James Russell January 1976 (has links)
This document only includes an excerpt of the corresponding thesis or dissertation. To request a digital scan of the full text, please contact the Ruth Lilly Medical Library's Interlibrary Loan Department (rlmlill@iu.edu).
|
93 |
Development of an immunoassay for the quantification of capsaicinoids in different matrices.Wang, Yong 01 January 1997 (has links) (PDF)
No description available.
|
94 |
APPLICATIONS OF MICROBEAD-BASED ELECTROCHEMICAL IMMUNOASSAYTHOMAS, JENNIFER HODGES January 2003 (has links)
No description available.
|
95 |
A Nonlinear Mixed Modeling Method to Analyze Allergen Assay Data and the Effects of Exposures Two Indoor Aeroallergens During Infancy on Children at Age Three: The CCAAPS CohortLiang, Juan 04 December 2009 (has links)
No description available.
|
96 |
MAGNETIC PARTICLE SEPARATORS AND INTEGRATED BIOFILTERS FOR MAGNETIC BEAD-BASED BIOCHEMICAL DETECTION SYSTEMCHOI, JIN-WOO 11 October 2001 (has links)
No description available.
|
97 |
5-Fluorouracil-Spiegelbestimmung unter neoadjuvanter Radiochemotherapie und adjuvanter Chemotherapie beim lokal fortgeschrittenen Rektumkarzinom / Effects of a body surface area based 5-fluoruracil dosing under the neoadjuvant radiochemotherapy and adjuvant chemotherapy in locally advanced rectal cancerQuack, Henriette 19 May 2015 (has links)
No description available.
|
98 |
Magnetic bead detection with ferromagnetic resonance for use in immuno-biosensor applicationGhionea, Simon 03 June 2009 (has links)
The objective of this thesis is to introduce and demonstrate a novel magnetic bead detector based on inductive detection at the ferromagnetic resonance (FMR) frequency for use in bio-sensing applications. Detection ability is demonstrated through theoretical arguments, numerical computer simulations, and experimental characterization of micro-fabricated detectors.
The detector is composed of two uniplanar rf waveguides (coplanar waveguide and slotline) terminated together at a short-circuit junction, which serves as the sensitive area.
Experimental characterization of a micro-fabricated junction gives a signal ranging between 1 microvolt/volt and 12 microvolts/volt, depending on the number of beads at the junction as well spatial distribution of the beads. The locations around the tips of the CPW were shown to be the most sensitive.
A more complex rf circuit design was created employing the detection junction, and detection of magnetic beads was successfully shown at rf frequencies around 6 GHz in this configuration. Due to lack of FMR characterization data for magnetic beads in the literature, several varieties of magnetic beads were characterized using a CPW transmission line and custom apparatus to determine FMR properties. Finally, successful detection of magnetic beads was demonstrated in a system-level integration experiment employing the detector junction in combination with microfluidics and bio-chemical surface modifications. / Graduation date: 2010
|
99 |
Detection of Anti-hGH Antibodies in Serum Samples of Children Treated with RhGHRitter, Nina 22 October 2012 (has links) (PDF)
The present study deals with the comparison and establishment of methods for the detection of antibodies against recombinant human growth hormone (rhGH). Therefore, different methods for the detection of hGH-Abs were evaluated and compared in order to establish a test system that can be used for the detection of neutralizing antibodies against hGH, which could be developed under rhGH treatment. This manuscript describes in detail the validation of a newly developed biological assay, the neutralizing hGH-antibody assay (NAb assay). Therefore, a cell line transfected with the growth hormone receptor, that proliferates in the presence of hGH, was used. This proliferation was quantified by an increase of the optical density (OD/ absorbance) after addition of a colorimetric reagent, whereas the presence of hGH-antibodies leads to an inhibition of cell proliferation.
To validate the test system for the detection of hGH-antibodies, we tested serum samples of 4 patients suffering from neurosecretory dysfunction (NSD) and samples taken from 6 patients with growth hormone deficiency (GHD) which were treated with rhGH and were highly suspected for a-hGH antibodies. These samples were tested in two different immunological assays, capable to screen sera for anti-hGH immunreactivity in the case of hGH-insensitivity during GH treatment. Using the NAb assay the neutralizing activity of specific hGH-antibodies was proved in serum samples of NSD and GHD type 1A patients.
In case of neutralizing hGH-antibody activity, a clinically based decision can be made whether rhGH therapy should be stopped or the rhGH dosis should be increased. By the use of our test system, we offer the measurement of anti-hGH-antibody activity to other laboratories in cases when secondary hGH-insensitivity is assumed or observed.
|
100 |
Optimization and Ultimate Limitations for Immunoassay and Clinical DiagnosticsJanuary 2015 (has links)
abstract: Biological fluids, in particular blood plasma, provide a vital source of information on the state of human health. While specific detection of biomarker species can aid in disease diagnostics, the complexity of plasma makes analysis challenging. Despite the challenge of complex sample analysis, biomarker quantification has become a primary interest in biomedical analysis. Due to the extremely specific interaction between antibody and analyte, immunoassays are attractive for the analysis of these samples and have gained popularity since their initial introduction several decades ago. Current limitations to diagnostics through blood testing include long incubation times, interference from non-specific binding, and the requirement for specialized instrumentation and personnel. Optimizing the features of immunoassay for diagnostic testing and biomarker quantification would enable early and accurate detection of disease and afford rapid intervention, potentially improving patient outcomes. Improving the limit of quantitation for immunoassay has been the primary goal of many diverse experimental platforms. While the ability to accurately quantify low abundance species in a complex biological sample is of the utmost importance in diagnostic testing, models illustrating experimental limitations have relied on mathematical fittings, which cannot be directly related to finite analytical limits or fundamental relationships. By creating models based on the law of mass action, it is demonstrated that fundamental limitations are imposed by molecular shot noise, creating a finite statistical limitation to quantitative abilities. Regardless of sample volume, 131 molecules are necessary for quantitation to take place with acceptable levels of uncertainty. Understanding the fundamental limitations of the technique can aid in the design of immunoassay platforms, and assess progress toward the development of optimal diagnostic testing. A sandwich-type immunoassay was developed and tested on three separate human protein targets: myoglobin, heart-type fatty acid binding protein, and cardiac troponin I, achieving superior limits of quantitation approaching ultimate limitations. Furthermore, this approach is compatible with upstream sample separation methods, enabling the isolation of target molecules from a complex biological sample. Isolation of target species prior to analysis allows for the multiplex detection of biomarker panels in a microscale device, making the full optimization of immunoassay techniques possible for clinical diagnostics. / Dissertation/Thesis / Doctoral Dissertation Chemistry 2015
|
Page generated in 0.052 seconds